Stock Events

Stock Events

Merrimack Pharmaceuticals 

0
0
+€0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
Dec 19
€0.45
Sep 19
€1.36
May 17
€0.95
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Bristol-Myers Squibb
BMY
Mkt Cap136B
Bristol-Myers Squibb is a leading biopharmaceutical company focusing on cancer, a direct competition to Merrimack's oncology focus.
Merck
MRK
Mkt Cap366B
Merck & Co., Inc. specializes in cancer treatments and vaccines, directly competing in the oncology space.
Pfizer
PFE
Mkt Cap159.36B
Pfizer Inc. has a broad portfolio including oncology, directly competing with Merrimack's cancer therapies.
Gilead Sciences
GILD
Mkt Cap180.64B
Gilead Sciences, Inc. focuses on antiviral drugs and cancer treatments, making it a competitor in the oncology market.
AMGEN
AMGN
Mkt Cap233.78B
Amgen Inc. is a biotech firm with a strong emphasis on cancer and serious illness treatments, competing in the same space.
Abbvie
ABBV
Mkt Cap451.46B
AbbVie Inc. has a diverse biopharmaceutical portfolio including oncology, directly competing with Merrimack.
Regeneron Pharmaceuticals
REGN
Mkt Cap81.77B
Regeneron Pharmaceuticals, Inc. is known for its innovative treatments in oncology, among other areas, competing with Merrimack.
Novartis
NVS
Mkt Cap292.35B
Novartis AG focuses on a wide range of healthcare areas including oncology, making it a direct competitor.
Astrazeneca
AZN
Mkt Cap252.33B
AstraZeneca PLC has a strong focus on oncology, respiratory diseases, and more, competing in the cancer treatment space.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson, through its pharmaceutical division Janssen, competes in the oncology market, among other healthcare sectors.

About

Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was founded in 1993 and is headquartered in Cambridge, Massachusetts.
Show more...
CEO
Mr. Gary L. Crocker M.B.A., MBA
Country
United States
ISIN
US5903282094

Listings

STU
DE
MP6N.STU

0 Comments

Share your thoughts

FAQ

What is Merrimack Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Merrimack Pharmaceuticals stocks are traded under the ticker MP6N.STU.
Does Merrimack Pharmaceuticals pay dividends?▼
Yes, MP6N.STU dividends are paid annual. The last dividend per share was 0.45 EUR. As of today, Dividend Yield (FWD)% is 0%.
In which sector is Merrimack Pharmaceuticals located?▼
Merrimack Pharmaceuticals operates in the Health & Wellness sector.
When did Merrimack Pharmaceuticals complete a stock split?▼
Merrimack Pharmaceuticals has not had any recent stock splits.
Where is Merrimack Pharmaceuticals headquartered?▼
Merrimack Pharmaceuticals is headquartered in Cambridge, United States.